Log in to save to my catalogue

Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to...

Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_671e1303a548439c811055b9bfe4b17f

Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to targeted therapy in melanoma

About this item

Full title

Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to targeted therapy in melanoma

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2022-03, Vol.14 (3), p.e15295-n/a

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Lineage dedifferentiation toward a mesenchymal‐like state displaying myofibroblast and fibrotic features is a common mechanism of adaptive and acquired resistance to targeted therapy in melanoma. Here, we show that the anti‐fibrotic drug nintedanib is active to normalize the fibrous ECM network, enhance the efficacy of MAPK‐targeted therapy, and de...

Alternative Titles

Full title

Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to targeted therapy in melanoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_671e1303a548439c811055b9bfe4b17f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_671e1303a548439c811055b9bfe4b17f

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.202115295

How to access this item